retatrutide effects on libido Sexual Function Impact: What the Phase 2 Data Actually Show retatrutide effect on libido Retatrutide

The FDA Adverse Event Reporting System (FAERS) collects post-marketing safety reports, but such spontaneous reporting systems have inherent limitations and cannot establish causation or absence of risk

Vasc Health Risk Manag

Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake

Adherence to GLP-1 RA therapy may be improved by slowing dose escalation, as per label instructions, and setting patient expectations for possible gastrointestinal adverse outcomes that should subside over time